Overview

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether tranilast at two different dosages compared to placebo is effective in patients with active RA when added to continuing methotrexate (MTX) therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Nuon Therapeutics, Inc.
Treatments:
Tranilast